Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

I think BE results will be released this morning.

Thanks.

SEQUESTOX PIVOTAL BE

Completion Time: 50 DAYS

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study For Second Opioid Abuse Deterrent Product

Northvale, New Jersey, Tuesday, January 14, 2014: Elite Pharmaceuticals, Inc. ("Elite" or the “Company") ("Elite”) (OTCBB: ELTP) announced today the first dosing of a pivotal bioequivalence study in healthy volunteers for an undisclosed opioid abuse deterrent product utilizing Elite’s proprietary pharmacological abuse deterrent technology.

Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study For Abuse Deterrent Product ELI-200

Northvale, New Jersey, Wednesday, March 05, 2014: Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) announced today successful results from a pivotal bioequivalence study initiated in January 2014 for Elite’s undisclosed abuse deterrent opioid product, ELI-200.
-------------------------------------------------------------------------------------------------------

REFORMULATED SEQUESTOX PIVOTAL BE

Monday, May 1 = 48 DAYS

Elite Pharmaceuticals, Inc. Initiates Pivotal Bioequivalence Fed Study For Reformulated SequestOx™

NORTHVALE, N.J., March 13, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), announced today that it has initiated pharmacokinetic testing of its reformulated SequestOx™.